Sou Nakamura

Kawahara, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation.

Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation.

Journal: Journal of pharmacological sciences

Published: April 15, 2026

Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcγRIIA engagement.

Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcγRIIA engagement.

Journal: Research and practice in thrombosis and haemostasis

Published: October 10, 2025

Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets.

Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets.

Journal: Bone

Published: June 11, 2025

Aging-dependent reduction of KAT7/HBO1 activity impairs imMKCL-based platelet production by promoting immune properties.

Aging-dependent reduction of KAT7/HBO1 activity impairs imMKCL-based platelet production by promoting immune properties.

Journal: Stem cell reports

Published: March 14, 2025

A Case of Partial Cystectomy for Spontaneous Intraperitoneal Rupture of the Bladder Revealed from Hemorrhagic and Septic Shock.

A Case of Partial Cystectomy for Spontaneous Intraperitoneal Rupture of the Bladder Revealed from Hemorrhagic and Septic Shock.

Journal: Juntendo medical journal

Published: December 02, 2024

KCNN4-mediated potassium ion efflux maintains mitochondrial functions leading to platelet biogenesis.

KCNN4-mediated potassium ion efflux maintains mitochondrial functions leading to platelet biogenesis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 06, 2024

Osteogenic effects and safety of human induced pluripotent stem cell-derived megakaryocytes and platelets produced on a clinical scale.

Osteogenic effects and safety of human induced pluripotent stem cell-derived megakaryocytes and platelets produced on a clinical scale.

Journal: Regenerative therapy

Published: July 25, 2024

A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility.

A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility.

Journal: Nature communications

Published: July 06, 2023

Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.

Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.

Journal: Biochemical and biophysical research communications

Published: April 12, 2023

Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.

Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.

Journal: Blood advances

Published: July 08, 2022

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.

Journal: Blood

Published: June 02, 2022

A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells.

A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells.

Journal: ALTEX

Published: November 18, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026